Search research articles
Contact Us
Filters
Showing results (351-360 of 427) with videos related to
Page
of 43
Sort By:
Lupus
|
May 15, 2015
Electroconvulsive therapy as a treatment for refractory neuropsychiatric lupus with catatonia: three case studies and literature review
B E R G Bica, A L D Moro, V Hax, et al.
Mycoses
|
September 2, 2020
Acanthamoeba castellanii as an alternative interaction model for the dermatophyte Trichophyton rubrum
Lucas V de Faria, Paulo H F do Carmo, Marliete C da Costa, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 9, 2008
Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism
Aysun Karatas, Björn Hegner, Leon J de Windt, et al.
Epilepsy Research
|
October 1, 1993
Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function
P R Bittencourt, S A Antoniuk, M M Bigarella, et al.
Emerging Infectious Diseases
|
December 8, 2009
Cross-sectional survey of hantavirus infection, Brazil
Jean E Limongi, Fabíola C da Costa, Rogério M C Pinto, et al.
Toxins
|
June 1, 2018
Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against <i>Mycobacterium massiliensis</i>
Lázaro M Marques-Neto, Monalisa M Trentini, Rogério C das Neves, et al.
RNA Biology
|
September 5, 2015
The unique Leishmania EIF4E4 N-terminus is a target for multiple phosphorylation events and participates in critical interactions required for translation initiation
Osvaldo P de Melo Neto, Tamara D C da Costa Lima, Camila C Xavier, et al.
Oncogene
|
July 1, 2026
Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, et al.
Oncogene
|
January 17, 2017
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, et al.
AJNR. American Journal of Neuroradiology
|
August 27, 2021
The Brain Metabolic Signature in Superagers Using In Vivo <sup>1</sup>H-MRS: A Pilot Study
L L de Godoy, A Studart-Neto, M Wylezinska-Arridge, et al.
Page
of 43
Search research articles
Search
Showing results (351-360 of 427) with videos related to
Sort By:
Page
of 43
Lupus
|
May 15, 2015
Electroconvulsive therapy as a treatment for refractory neuropsychiatric lupus with catatonia: three case studies and literature review
B E R G Bica, A L D Moro, V Hax, et al.
Mycoses
|
September 2, 2020
Acanthamoeba castellanii as an alternative interaction model for the dermatophyte Trichophyton rubrum
Lucas V de Faria, Paulo H F do Carmo, Marliete C da Costa, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 9, 2008
Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism
Aysun Karatas, Björn Hegner, Leon J de Windt, et al.
Epilepsy Research
|
October 1, 1993
Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function
P R Bittencourt, S A Antoniuk, M M Bigarella, et al.
Emerging Infectious Diseases
|
December 8, 2009
Cross-sectional survey of hantavirus infection, Brazil
Jean E Limongi, Fabíola C da Costa, Rogério M C Pinto, et al.
Toxins
|
June 1, 2018
Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against <i>Mycobacterium massiliensis</i>
Lázaro M Marques-Neto, Monalisa M Trentini, Rogério C das Neves, et al.
RNA Biology
|
September 5, 2015
The unique Leishmania EIF4E4 N-terminus is a target for multiple phosphorylation events and participates in critical interactions required for translation initiation
Osvaldo P de Melo Neto, Tamara D C da Costa Lima, Camila C Xavier, et al.
Oncogene
|
July 1, 2026
Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, et al.
Oncogene
|
January 17, 2017
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
S Ros, J Flöter, I Kaymak, et al.
AJNR. American Journal of Neuroradiology
|
August 27, 2021
The Brain Metabolic Signature in Superagers Using In Vivo <sup>1</sup>H-MRS: A Pilot Study
L L de Godoy, A Studart-Neto, M Wylezinska-Arridge, et al.
Page
of 43